XML 54 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
6 Months Ended 76 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss $ (1,161,625) $ (463,651) $ (7,010,531)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation 16,992 16,249 185,190
Allowance for uncollectible notes receivable       38,867
Amortization of debt discount 51,437    53,657
Amortization of deferred finance costs    40,402 59,605
Interest (income) expense on fair value adjustment on convertible notes payable (4,464) 7,721 445,889
Interest accrued on note receivable       (11,705)
Write-off of uncollectible deposit       20,000
Loss on extinguishment of debt    31,398 381,113
Loss on impairment       42,800
Stock issued for services 937,037 76,885 2,833,387
Stock issued for financing fees       5,000
Changes in operating assets and liabilities:      
Prepaid expenses (182,862)    (231,122)
Advances to shareholders       (1,015)
Deposits and other receivables       (23,346)
Accounts payable and accrued liabilities 4,223 12,658 236,424
Net cash used in operating activities (342,262) (278,338) (2,975,787)
CASH FLOWS FROM INVESTING ACTIVITIES      
Issuance of notes receivable       (25,000)
Purchase of investment in common stock    (12,000) (34,100)
Acquisition of equipment       (325,000)
Net cash used in investing activities    (12,000) (384,100)
CASH FLOWS FROM FINANCING ACTIVITIES      
Proceeds from the issuance of common stock 193,843 139,000 2,241,387
Proceeds from the issuance of convertible notes, related parties 55,500 50,000 111,500
Proceeds from the issuance of convertible notes, non related parties 79,000 72,500 841,800
Proceeds from the issuance of notes payable    30,000 286,500
Proceeds from the issuance of notes payable - related parties       8,500
Payments on convertible notes payable (30,000)    (76,000)
Payments on notes payable    (10,000) (57,500)
Payments on notes payable - related parties       (1,000)
Proceeds from loans from stockholders       40,925
Payments on loans from stockholders       (36,225)
Net cash provided by financing activities 298,343 281,500 3,359,887
NET DECREASE IN CASH (43,919) (8,838)   
CASH, BEGINNING OF PERIOD 43,919 8,838   
CASH, ENDING OF PERIOD         
NONCASH FINANCING ACTIVITIES:      
Due to Organetix, Inc. reclassified to additional paid-in capital       91,500
Common stock issued in conjunction with a joint venture       9,800
Common stock issued to satisfy debt    70,851 76,528
Common stock issued to satisfy minimum value guarantee       87,667
Convertible debt converted to common stock including accrued interest 127,416 91,259 1,340,438
Common stock issued in exchange for a fixed asset       7,420
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:      
Interest       $ 3,660